NCT05707013

Brief Summary

Currently 77% of Americans experience foot pain, of which a large portion can be attributed to plantar fasciitis. The Arize Orthotic solution, developed in collaboration with podiatrists and leading industry experts, is a new digital solution that helps podiatrists create custom foot orthoses tailored to the patient, quickly, easily, accurately, and reliably. This pilot study will evaluate the effectiveness and clinical benefit of 3D printed foot orthotics compared to traditionally fabricated custom-made orthotics and assess compliance and patient satisfaction in patients with plantar fasciitis.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
2mo left

Started Jan 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Jan 2023Jun 2026

Study Start

First participant enrolled

January 19, 2023

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

January 20, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 31, 2023

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

February 5, 2026

Status Verified

February 1, 2026

Enrollment Period

3.4 years

First QC Date

January 20, 2023

Last Update Submit

February 4, 2026

Conditions

Keywords

orthotics

Outcome Measures

Primary Outcomes (1)

  • Patient-reported compliance and satisfaction with orthotics.

    Patient-reported compliance with traditionally fabricated or 3D-printed orthotics will be assessed at 4 weeks and 8 weeks post-initiation of orthotic wearing via a study-specific survey. This survey includes questions related to how often the patient wore their orthotics, the ease of the process, and fit and feel of the orthotics, and any experienced side effects. This survey was developed by the research team and includes subjective responses to questions; there is no score associated with this assessment.

    8 weeks

Secondary Outcomes (1)

  • Patient-reported secondary site pain following implementation of orthotics.

    8 weeks

Study Arms (2)

HP Arize 3D-Printed Orthotics

EXPERIMENTAL

Patients will receive the HP Arize 3D-printed orthotics for treatment of plantar fasciitis.

Device: HP Arize 3D-Printed Orthotics

Traditional Orthotics

ACTIVE COMPARATOR

Patients will receive traditionally fabricated orthotics for treatment of plantar fasciitis.

Device: Traditional Orthotics

Interventions

Custom 3D-printed orthotics manufactured by HP.

HP Arize 3D-Printed Orthotics

Traditionally fabricated custom orthotics manufactured by a local supplier.

Traditional Orthotics

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least 18 years of age
  • Diagnosis of plantar fasciitis
  • Access to methods of electronic communication (i.e., email)

You may not qualify if:

  • Previously prescribed and/or used orthotic inserts
  • Requires additional bracing of the lower leg
  • Diagnosis of neuropathy, acute fracture, or stress fracture
  • Pregnant women
  • Non-English speakers
  • Medicare patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prisma Health - Midlands

Lexington, South Carolina, 29072, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients will be randomized to receive traditionally fabricated orthotics or HP Arize 3D-printed orthotics for treatment of plantar fasciitis.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 20, 2023

First Posted

January 31, 2023

Study Start

January 19, 2023

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

February 5, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations